Restoring Nerve Function

Solaxa is a clinical-ready biopharmaceutical company developing treatments for
rare neurodegenerative disease and nerve injury.

 

We are pursuing both novel and reformulated drugs to
restore nerve function by targeting ion channels.

Our Company: By The Numbers

9

Different ataxias have shown treatment response with drug

13

5 issued and 8 pending US, EU, Canada patents exclusively licensed

240

Cerebellar ataxia patients studied with drug

$12M+

Non-dilutive NIH & DoD grants to co-founders

20+

Peer-reviewed publications by co-founders

Scroll to Top